Hybridan

Our passion is raising growth capital for exciting, fast growth companies that want to take their business to the next level. We raise capital for companies both listed and unlisted in the most efficient manner possible and pride ourselves as being one of the few consistently profitable broking firms in the City. This has been achieved through a highly disciplined approach when seeking to create both corporate and institutional relationships.

Your Partner for Growth

Your Partner for Growth, Hybridan

Equity Bottom-Up

<ul>
<li>The independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity announced its intention to commence a share buyback programme with an aggregate value of up to £3m.</li>
<li>As referenced in the Company's final results for the year ended 31 December 2025, announced on 31 March 2026, the Company had a cash position of approximately £12.4m.</li>
<li>The Board considers that the Company's strong balance sheet and cash generation provides the opportunity to take advantage of current market conditions to repurchase shares at attractive levels and the Programme reflects continued confidence in the Company's future prospects.</li>
</ul>


The independent manufacturer of natural sustainable animal feed additives for health, nutrition and biosecurity announced its intention to commence a share buyback programme with an aggregate value of up to £3m.
As referenced in the Company's final results for the year ended 31 December 2025, announced on 31 March 2026, the Company had a cash position of approximately £12.4m.
The Board considers that the Company's strong balance sheet and cash generation provides the opportunity to take advantage of current market conditions to repurchase shares at attractive levels and the Programme reflects continued confidence in the Company's future prospects.


Shield Therapeutics Plc - Hybridan Small Cap Feast: 27 April 2026